Avoidance responding following amphetamine-induced dopamine depletion

Pharmacology and Toxicology

Volumn 87, Issue 5, 2000, Pages 211-217

  Halladay, Alycia K ^a   Coyne, Thomas ^a   Sharifi, Jill ^a   Seto, Jeremy ^a   Wagner, George C ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 5 HYDROXYINDOLEACETIC ACID; AMPHETAMINE; DOPAMINE; HALOPERIDOL; HOMOVANILLIC ACID; SEROTONIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINE RELEASE; DOSE RESPONSE; DRUG MECHANISM; LEARNING; MALE; MOTOR PERFORMANCE; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0033709668     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0773.2000.d01-76.x     Document Type: Article

References (39)

1. Agid, Y., F. Javoy-Agid & M. Ruberg: Biochemistry of neurotransmitters in Parkinson's Disease. Movement Disorders 1987, 2, 166-230.
2. Albers, D. S. & P. K. Sonsalla: Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: Pharmacological profile of protective and nonprotective agents. J. Pharmacol. Exp. Therap. 1995, 275, 1104-1114.
3. Ando, K., C. E. Johanson, L. S. Seiden & C. R. Schuster: Sensitivity changes to dopaminergic agents in fine motor control of rhesus monkeys after repeated methamphetamine administration. Pharmacol. Biochem. Behav. 1985, 22, 737-743.
4. Arnt, J.: Pharmacological specificity of conditioned avoidance response inhibition in rats: inhibition by neuroleptics and correlation to dopamine receptor blockade. Acta pharmacol. et toxicol. 1982, 51, 321-329.
5. Ashford, J. & B. J. Jones: The effects of intra-amygdaloid injections of 6-hydroxydopamine on avoidance responding in rats. Brit. J. Pharmacol. 1976, 56, 255-261.
6. Beninger, R. J., S. T. Mason, A. G. Phillips & H. C. Fibiger: The use of conditioned suppression to evaluate the nature of neuroleptic-induced avoidance deficits. J. Pharmacol. Exp. Therap. 1980, 213, 623-627.
7. Blackburn, J. R. & A. G. Phillips: Blockade of acquisition of one-way conditioned avoidance responding by haloperidol and metoclopramide but not by thiroidazine or clozapine: implications for screeening new antipsychotic drugs. Psychopharmacology 1989, 98, 453-459.
8. Blackburn, J. R., J. G. Pfaus & A. G. Phillips: Dopamine functions in appetitive and defensive behaviors. Progr. Neurobiol. 1992, 39, 247-279.
9. Cooper, B. R., G. R. Breese, L. D. Grant & J. L. Howard: Effects of 6-hydroxydopamine treatments on active avoidance responding: evidence for involvement of brain dopamine. J. Pharmacol Exp. Therap. 1973, 185, 358-370.
10. DeVito, M. J., W. J. Brooks & G. C. Wagner: Behavioral deficits following intracranial administration of MPP+ to the rat. Res. Com. Psychol., Psychiat. Behav. 1987, 12, 65-74.
11. Fibiger, H. C., A. G. Phillips & A. P. Zis: Deficits in instrumental responding after 6-hydroxydopamine lesions of the nigro-neostriatal dopaminergic projection. Pharmacol., Biochem. Behav. 1974, 2, 87-96.
12. Fibiger, H. C., A. P. Zis & A. G. Phillips: Haloperidol induced disruption of conditioned avoidance responding: attenuation by prior training or by anticholinergic drugs. Eur. J. Pharmacol. 1975, 30, 309-314.
13. Fields, J. Z., W. Wichlinski, G. E. Drucker, K. Engh & J. H. Gordon: Long-lasting dopamine receptor up-regulation in amphetamine-treated rats following amphetamine neurotoxicity. Pharmacol. Biochem. Behav. 1991, 40, 881-886.
14. Finnegan, K. T., G. Ricuarte, L. S. Seiden & C. R. Schuster. Altered sensitivity to d-methylamphetamine, apomorphine and haloperidol in rhesus monkeys depleted of caudate dopamine by repeated administration of d-methylamphetamine. Psychopharmacol. 1982, 77, 43-52.
15. Gordon, C. J. & L. Fogelson: Metabolic and thermoregulatory responses of the rat maintained in acrylic or wire-screen cages: implication for pharmacological studies. Physiology & Behavior 1994, 56, 73-79.
16. Gulley, J. M. & G. V. Rebec: Modulatory effect of ascorbate, alone or with haloperidol, on a lever-release conditioned avoidance response task. Pharmacol Biochem. Behav. 1999, 63, 125-129.
17. Halladay, A. K., H. Fisher & G. C. Wagner: Interaction of phentermine plus fenfluramine: neurochemical and neurotoxic effects. Neurotoxicology 1998, 19, 177-184.
18. Hornykiewicz, O.: Parkinson's disease: from brain homogenate to treatment Fed. Proc. 1973, 32, 183-190.
19. Hornykiewicz, O. & S. J. Kish: Biochemical pathophysiology of Parkinson's disease. Adv. Neurol. 1986, 45, 19-34.
20. Ichihara, K., T. Nabeshima & T. Kameyama: Opposite effects induced by low and high doses of apomorphine on single-trial passive avoidance learning in mice. Pharmacol. Biochem. Behav. 1988, 30, 107-113.
21. Johnson, S. K., H. Fisher & G. C. Wagner: Partial 6-hydroxydopamine-induced lesions and haloperidol-induced catalepsy. Neuropharmacology 1993, 32, 273-278.
22. Kita, T., M. Takahashi, G. C. Wagner, K. Kubo & T. Nakashima: Methamphetamine-induced changes in activity and water intake during light and dark cycles in rats. Progr. Neuro-Psychopharmacology & Biological Psychiatry 1998a, 22, 1185-1197.
23. Kita, T., S. Paku, M. Takahashi, K. Kubo, G. C. Wagner & T. Nakashima: Methamphetamine-induced neurotoxicity in BALB/c, DBA/2N and C57BL/6N mice. Neuropharmacology 1998b, 37, 1177-1184.
24. Koob, G. F, H. Simon, J. P. Herman & M. Le Moal: Neurolepticlike disruption of the conditoned avoidance response requires destruction of both the mesolimbic and nigrostriatal dopamine systems. Brain Res. 1984, 303, 319-329.
25. Miller, D. B. & J. P. O'Callaghan: Environment-, drug- and stress-induced alterations in body temperature affect the neurotoxicity of substituted amphetamines in the C57BL/6J mouse. J. Pharmacol. Exp. Therap. 1994, 270, 752-760.
26. Monti, J. M. & A. Ruiz: Increased disruptive effects of haloperidol on a conditioned avoidance response after 6-hydroxydopamine treatment. Pharmacol Biochem. Behav. 1975, 3, 943-945.
27. Myers, C. S., H. Fisher & G. C. Wagner: Uridine potentiates haloperidol's disruption of conditioned avoidance responding. Brain Res. 1994, 651, 194-198.
28. Myers, C. S., A. K. Halladay, D. A. J. Widmer & G. C. Wagner: Neurotoxic effects of amphetamine plus 1-dopa. Prog. Neuro-Psychopharmacology & Biological Psychiatry 1999, 23, 731-741.
29. Nakagawa, T., K. Ukai, T. Ohyama, Y. Gomita & H. Okamura: Effects of dopaminergic agents on reversal of reserpine-induced impairment of conditioned avoidance response in rats. Pharmacol. Biochem. Behav. 1997, 58, 829-836.
30. Preston, K., G. C. Wagner, C. R. Schuster & L. S. Seiden: Longterm effects of repeated methylamphetamine administration on monoamine neurons in the rhesus monkey brain. Brain Res. 1985, 338, 243-248.
31. Price, M. T. C. & H. C. Fibiger: Discriminated escape learning and response to electric shock after 6-hydroxydopamine lesions of the nigro-neostriatal dopaminergic projection. Pharmacol. Biochem. Behav. 1975, 3, 285-290.
32. Seiden, L. S. & A. Carlsson: Temporary and partial antagonism by L-dopa of reserpine-induced suppresion of a conditioned avoidance response. Psychopharmacologia 1963, 6, 418-423.
33. Taboada, M. E., M. Souto, H. Hawkins & J. M. Monti: The actions of dopaminergic and noradrenergic antagonists on conditioned avoidance responses in intact and 6-hydroxydopamine-treated rats. Psychopharmacology 1979, 62, 83-88.
34. Wagner, G. C, L. S. Seiden & C. R. Schuster: Methamphetamine-induced changes in brain catecholamines in rats and guinea pigs. Drug Alcohol Dependence 1979, 4, 435-438.
35. Wagner, G. C., G. A. Ricauarte, L. S. Seiden, C. R. Schuster, R. J. Miller & J. Westley: Long lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine. Brain Res. 1980a, 181, 151-160.
36. Wagner, G. C., G. A. Ricauarte, C. E. Johanson, C. R. Schuster & L. S. Seiden: Amphetamine induces depletion of dopamine and loss of dopamine uptake sites in caudate. Neurology 1980b, 30, 547-550.
37. Wagner, G. C., M. F. Jarvis & J. G. Rubin: L-dopa reverses the effects of MPP+ toxicity. Psychopharmacology 1986, 88, 401-402.
38. Wallace, T. L., G. A. Gudelsky & C. V. Vorhees: Methamphetamine-induced neurotoxicity alters locomotor activity, stereotypic behavior, and stimulated dopamine release in the rat. J. Neurosc. 1999, 19, 9141-9148.
39. Walsh, S. L. & G. C. Wagner: Motor impairments after methamphetamine-induced neurotoxicity in the rat. J. Pharmacol. Exp. Therap. 1992, 263, 617-626.